(Q53579494)

English

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.

scientific article published in April 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

author name string

Barone C

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Corsi DC

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Pozzo C

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Cassano A

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Fontana T

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Noviello MR

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Landriscina M

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Colloca G

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Astone A

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

82

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

1460-1467

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Current advances in the treatment of gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Enhancement of the antitumor effects of 5-fluorouracil by folinic acid

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Enhancement of cisplatin activity by lonidamine in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Appropriate chemotherapy for palliating advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Chemotherapy of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Folate biochemical modulation regimen for the treatment of gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Continuous 5-Fluorouracil Infusion in Advanced Gastric Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Efficacy of the association of folinic acid and 5-fluorouracil alone versus folinic acid and 5-fluorouracil plus 4-epidoxorubicin in the treatment of advanced gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980415%2982%3A8%3C1460%3A%3AAID-CNCR5%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980415)82:8<1460::AID-CNCR5>3.0.CO;2-D

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9554521

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53579494&oldid=1360725349"